A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration

International Journal of Artificial Organs

Volumn 28, Issue 12, 2005, Pages 1211-1218

  Egi, M ^a   Naka, T ^a   Bellomo, Rinaldo ^a,e   Cole, L ^b   French, C ^c   Trethewy, C ^d   Wan, L ^a   Langenberg, C C ^a   Fealy, N ^a   Baldwin, I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NEPEAN HOSPITAL   (Australia)

^c WESTERN HOSPITAL   (Australia)

^d Tamworth Base Hospital   (Australia)

^e AUSTIN HOSPITAL   (Australia)

Author keywords

Acute renal failure; Anticoagulation; Calcium; Citrate; Critical illness; Hemofiltration; Magnesium; Renal replacement therapy

Indexed keywords

CALCIUM; INTENSIVE CARE UNITS; IONIZATION; PATIENT MONITORING; PATIENT TREATMENT;

ACUTE RENAL FAILURE; ANTI-COAGULATION; CITRATE; CRITICAL ILLNESS; CRITICALLY-ILL PATIENTS; FILTER LIFE; FILTER REPLACEMENT; HEMOFILTRATION; RENAL FAILURE; RENAL REPLACEMENT THERAPIES;

MAGNESIUM;

BICARBONATE; CALCIUM ION; CITRIC ACID; HYPERTENSIVE FACTOR; MAGNESIUM CHLORIDE; SODIUM CHLORIDE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD FILTER; CONTINUOUS HEMOFILTRATION; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HUMAN; HYPOCALCEMIA; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METABOLIC ALKALOSIS; SAFETY; SEPTIC SHOCK; STATISTICAL ANALYSIS; TREATMENT WITHDRAWAL;

EID: 31644449094     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880502801203     Document Type: Article

References (23)

1. Bellomo R, Ronco C. Continuous renal replacement therapy: Continuous blood purification in the intensive care unit. Ann Acad Med Singapore 1998; 27: 426-9.
2. Bellomo R, Ronco C. Continuous versus intermittent renal replacement therapy in the intensive care unit. Kidney Int 1998; 66 (suppl): S125-8.
3. Ronco C. Continuous renal replacement therapies for the treatment of acute renal failure in intensive care patients. Clin Nephrol 1993; 40: 187-98.
4. Ward DM, Mehta RL. Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 1993; 41 (suppl): S237-44.
5. van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC. Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996; 7: 145-50.
6. Mehta RL, McDonald BR, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 months. Contrib Nephrol 1991; 93: 210-4.
7. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med 2004; 30: 260-5.
8. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999; 55: 1991-7.
9. Morgera S, Scholle C, Voss G, Haase M, Vargas-Hein O, Krausch D, Melzer C, Rosseau S, Zuckermann-Becker H, Neumayer HH. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: Single-center experience. Nephron Clin Pract 2004; 97: 131-6.
10. Swartz R, Pasko D, O'Toole J, Starmann B. Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation. Clin Nephrol 2004; 61: 134-43.
11. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001; 60: 370-4.
12. Mitchell A, Daul AE, Beiderlinden M, Schafers; RF, Heemann U, Kribben A, Peters J, Philipp T, Wenzel RR. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD). Clin Nephrol 2003; 59: 106-14.
13. Gupta M, Wadhwa NK, Bukovsky R. Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate. Am J Kidney Dis 2004; 43: 67-73.
14. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38: 976-81.
15. Kutsogiannis DJ, Mayers I, Chin WD, Gibney RT. Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 2000; 35: 802-11.
16. Cointault O, Kamar N, Bories P, Lavayssiere L, Angles O, Rostaing L, Genestal M, Durand D. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrol Dial Transplant 2004; 19: 171-8.
17. Hofmann RM, Maloney C, Ward DM, Becker BN. A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF). Ren Fail 2002; 24: 325-35.
18. Tobe SW, Aujla P, Walele AA, Oliver MJ, Naimark DM, Perkins NJ, Beardsall M. A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions. J Crit Care 2003; 18: 121-9.
19. Thoenen M, Schmid ER, Binswanger U, Schuepbach R, Aerne D, Schmidlin D. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients. Wien Klin Wochenschr 2002; 114: 108-14.
20. Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C. Citrate anticoagulation in continuous venovenous hemodiafiltration: A metabolic challenge. Intensive Care Med 2002; 28: 1419-25.
21. Dorval M, Madore F, Courteau S, Leblanc M. A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration. Intensive Care Med 2003; 29: 1186-9.
22. Langenecker SA, Felfernig M, Werba A, Mueller CM, Chiari A, Zimpfer M. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration. Crit Care Med 1994; 22: 1774-81.
23. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous is not continuous: The incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003; 29: 575-8.